查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930081

全球生物资讯市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Bioinformatics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

生物资讯市场的成长驱动因素

全球生物资讯市场已成为现代生命科学的关键支柱，其成长动力源于对海量生物数据进行管理、分析和解读的日益增长的需求。根据 Fortune Business Insights 预测，生物资讯市场规模预计在 2025 年达到 317.4 亿美元，并在 2026 年显着增长至 384.5 亿美元。在基因组学、药物研发和个人化医疗等领域的日益普及推动下，该市场预计到 2034 年将达到 1,182.5 亿美元，2026 年至 2034 年的复合年增长率 (CAGR) 为 15.08%。 生物资讯学将计算工具与生物科学结合，用于分析基因组学、蛋白质组学和代谢组学数据。这些能力对于理解疾病机制、发现新的药物标靶和改善临床疗效至关重要。全球慢性病发病率的上升以及临床和基因组学研究的快速发展是推动市场扩张的关键因素。

市场驱动因素与成长因素

生物资讯市场的主要成长驱动因素之一是政府和私人机构对基因组研究投入的不断增加。大规模基因组定序计画会产生大量资料集，而这些资料集的分析和解读需要先进的生物资讯平台。例如，对全基因组定序计画和罕见疾病研究的投资正在加速对生物资讯软体和服务的需求。

此外，生物资讯学在整个药物研发生命週期中发挥关键作用，包括标靶识别、分子建模、毒性预测和生物标记发现。这使得製药和生技公司能够缩短研发週期并降低研发成本，从而进一步加速其应用。

新冠疫情也对市场产生了正面影响。生物资讯工具被广泛用于分析病毒基因组序列、阐明突变模式以及支持疫苗研发。自 2021 年以来，这些解决方案在传染病研究和临床试验中的应用不断扩展，持续支撑着市场的稳定成长。

市场趋势：人工智慧与机器学习的融合

人工智慧 (AI) 和机器学习 (ML) 的融合是塑造全球生物资讯市场的关键趋势。这些技术有助于从复杂且非结构化的生物数据集中提取有意义的信息，改进预测模型，并实现个人化医疗。人工智慧驱动的生物资讯学平台正越来越多地应用于基因组学、表观遗传学和肿瘤学研究，从而提高数据分析的准确性和可扩展性。

市场区隔分析

依产品/服务划分

市场依产品/服务分为软体及服务两大类。

软体领域占市场主导地位，预计到 2026 年将占 79.67% 的市场占有率，这主要得益于定序、数据分析和视觉化平台在研究和药物发现领域的广泛应用。服务领域也保持稳定成长，这得益于临床研究和学术机构需求的不断增长。

依应用领域划分

应用领域包括基因体学、药理学、代谢组学、转录组学等。

基因组学领域占了最大的市场占有率，预计到2026年将达到35.29%，这主要得益于测序技术的持续进步以及公共和私人对基因组学研究投资的不断增加。药理学和代谢组学也是关键领域，因为它们在药物代谢和治疗开发中发挥重要作用。

依最终使用者划分

以最终用户划分，製药和生技公司将主导市场，预计到2026年将占45.13%的市场占有率。这一主导地位归功于策略联盟、研发支出的成长以及生物资讯学在精准医疗和肿瘤学计画中的整合。

区域考量

北美将在2025年以46.23%的市场占有率引领全球生物资讯市场，这得益于主要解决方案提供商的强大实力、完善的研究基础设施以及政府支持的基因组学计划。

欧洲将紧随其后，由于对个人化医疗和下一代定序的投资，将呈现显着成长。

亚太地区预计将在预测期内实现最高的复合年增长率，这主要得益于中国、日本和印度等国家临床试验的增加以及基因组学研究的拓展。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 关键产业趋势：併购、业务合作
  • 生物资讯科技进步
  • 新冠疫情对市场的影响

第五章 全球生物资讯市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 软体
    • 服务
  • 市场分析、洞察与预测：依应用领域划分
    • 代谢组学
    • 药理学
    • 基因体学
    • 转录组学
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 製药和生技公司
    • 合约研究组织 (CRO)、研究机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

章节第六章 北美生物资讯市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲生物资讯市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章 亚太生物资讯市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 亚太其他地区

第九章：拉丁美洲生物资讯市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲生物资讯市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）成员国
    • 南非
    • 中东和非洲其他地区

第十一章 竞争格局分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • DNAnexus, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • IBM Corporation
    • Labvantage-Biomax GmbH
    • Genebio
    • Compugen Ltd.
    • Eurofins Scientific
    • QIAGEN
Product Code: FBI109493

Growth Factors of bioinformatics Market

The global bioinformatics market has emerged as a critical pillar of modern life sciences, driven by the growing need to manage, analyze, and interpret vast volumes of biological data. According to Fortune Business Insights, the bioinformatics market size was valued at USD 31.74 billion in 2025 and is projected to expand significantly to USD 38.45 billion in 2026. With increasing adoption across genomics, drug discovery, and personalized medicine, the market is forecasted to reach USD 118.25 billion by 2034, registering a strong CAGR of 15.08% during 2026-2034.

Bioinformatics integrates computational tools with biological sciences to analyze genomic, proteomic, and metabolomic data. These capabilities are increasingly vital for understanding disease mechanisms, discovering novel drug targets, and improving clinical outcomes. The rising global burden of chronic diseases and the rapid growth in clinical and genomic research are key contributors to market expansion.

Market Drivers and Growth Factors

One of the primary growth drivers of the bioinformatics market is the increased funding for genomics research by governments and private organizations. Large-scale genome sequencing initiatives generate enormous datasets that require advanced bioinformatics platforms for analysis and interpretation. For instance, investments in whole-genome sequencing programs and rare disease research are accelerating demand for bioinformatics software and services.

Additionally, bioinformatics plays a crucial role across the entire drug discovery lifecycle, including target identification, molecular modeling, toxicity prediction, and biomarker discovery. This has enabled pharmaceutical and biotechnology companies to shorten development timelines and reduce R&D costs, further driving adoption.

The COVID-19 pandemic also had a positive impact on the market. Bioinformatics tools were extensively used to analyze viral genome sequences, understand mutation patterns, and support vaccine development. Since 2021, the expanded application of these solutions in infectious disease research and clinical trials has continued to support steady market growth.

Market Trends: AI and Machine Learning Integration

A major trend shaping the global bioinformatics market is the integration of artificial intelligence (AI) and machine learning (ML). These technologies help extract meaningful insights from complex and unstructured biological datasets, improve predictive modeling, and enable personalized medicine. AI-driven bioinformatics platforms are increasingly used in genomics, epigenetics, and oncology research, enhancing accuracy and scalability in data analysis.

Market Segmentation Analysis

By Offering

Based on offerings, the market is segmented into software and services.

The software segment dominated the market, accounting for 79.67% share in 2026, due to high adoption of sequencing, data analysis, and visualization platforms in research and drug discovery. The services segment is also growing steadily, supported by rising demand from clinical research organizations and academic institutes.

By Application

By application, the market includes genomics, pharmacology, metabolomics, transcriptomics, and others.

The genomics segment held the largest share at 35.29% in 2026, driven by continuous advancements in sequencing technologies and increasing public and private investment in genomic research. Pharmacology and metabolomics also represent significant segments due to their importance in drug metabolism and therapeutic development.

By End User

In terms of end users, pharmaceutical and biotechnology companies dominated the market with a 45.13% share in 2026. This dominance is attributed to strategic collaborations, increased R&D spending, and the integration of bioinformatics into precision medicine and oncology programs.

Regional Insights

North America dominated the global bioinformatics market with a 46.23% share in 2025, supported by strong presence of leading solution providers, robust research infrastructure, and government-backed genomics initiatives.

Europe followed with notable growth due to investments in personalized medicine and next-generation sequencing.

The Asia Pacific region is expected to record the highest CAGR during the forecast period, fueled by rising clinical trials and expanding genomics research in countries such as China, Japan, and India.

Competitive Landscape

The bioinformatics market is moderately consolidated, with key players such as Illumina, QIAGEN, Thermo Fisher Scientific, Agilent Technologies, IBM Corporation, and Eurofins Scientific holding significant market positions. These companies focus on strategic partnerships, cloud-based platforms, and AI-enabled solutions to strengthen their global footprint.

Conclusion

In conclusion, the global bioinformatics market, valued at USD 31.74 billion in 2025, is set for robust expansion, reaching USD 118.25 billion by 2034. Strong investment in genomics research, technological advancements, and growing adoption in drug discovery and personalized medicine will continue to drive market growth during the forecast period.

Segmentation By Offering

  • Software
  • Services

By Application

  • Metabolomics
  • Pharmacology
  • Genomics
  • Transcriptomics
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • CROs & Research Institutes
  • Others

By Region

  • North America (By Offering, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Application, End-User, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Offering, Application, End-User, and Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Offering, Application, End-User, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Application, End-User, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.2. Technological Advancement in Bioinformatics
  • 4.3. Impact of COVID-19 on the Market

5. Global Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offerings
    • 5.1.1. Software
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Metabolomics
    • 5.2.2. Pharmacology
    • 5.2.3. Genomics
    • 5.2.4. Transcriptomics
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Pharmaceutical & Biotechnological Companies
    • 5.3.2. CROs & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offerings
    • 6.1.1. Software
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Metabolomics
    • 6.2.2. Pharmacology
    • 6.2.3. Genomics
    • 6.2.4. Transcriptomics
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Pharmaceutical & Biotechnological Companies
    • 6.3.2. CROs & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offerings
    • 7.1.1. Software
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Metabolomics
    • 7.2.2. Pharmacology
    • 7.2.3. Genomics
    • 7.2.4. Transcriptomics
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Pharmaceutical & Biotechnological Companies
    • 7.3.2. CROs & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia Pacific Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offerings
    • 8.1.1. Software
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Metabolomics
    • 8.2.2. Pharmacology
    • 8.2.3. Genomics
    • 8.2.4. Transcriptomics
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Pharmaceutical & Biotechnological Companies
    • 8.3.2. CROs & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Latin America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offerings
    • 9.1.1. Software
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Metabolomics
    • 9.2.2. Pharmacology
    • 9.2.3. Genomics
    • 9.2.4. Transcriptomics
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Pharmaceutical & Biotechnological Companies
    • 9.3.2. CROs & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offerings
    • 10.1.1. Software
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Metabolomics
    • 10.2.2. Pharmacology
    • 10.2.3. Genomics
    • 10.2.4. Transcriptomics
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Pharmaceutical & Biotechnological Companies
    • 10.3.2. CROs & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. DNAnexus, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Illumina, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Agilent Technologies, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Thermo Fisher Scientific Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. IBM Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Labvantage - Biomax GmbH
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Genebio
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Compugen Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Eurofins Scientific
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. QIAGEN
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 2: Global Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Bioinformatics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 6: North America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Bioinformatics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 10: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 14: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 18: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 22: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bioinformatics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bioinformatics Market Value Share (%), by Offerings, 2025 & 2034
  • Figure 3: Global Bioinformatics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Bioinformatics Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Bioinformatics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 7: North America Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 8: North America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 10: North America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 12: North America Bioinformatics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bioinformatics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 15: Europe Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 16: Europe Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 18: Europe Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 20: Europe Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 23: Asia Pacific Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 24: Asia Pacific Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 31: Latin America Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 32: Latin America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 39: Middle East & Africa Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 40: Middle East & Africa Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bioinformatics Market Share (%), By Company, 2025